Delayed Project Spending Characterizes Oceania's New Mining

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Delayed Project Spending Characterizes Oceania's New Mining Cycle, an Industrial Info News Alert

PERTH, AUSTRALIA--(Marketwired - Jan 19, 2016) - Researched by Industrial Info Resources Australia (Perth, Australia) -- Miners have significantly cut back their capital expenditures since the peaks of supply in 2011, and the Oceania region felt the heavy tail-end of this cutback in the first quarter of 2015. Massive investment reductions have taken place throughout that time, with some estimates asserting that coal is down by 60%, iron ore by 50%, gold by 27% and copper by more than 33%, according to investment management firm Van Eck Global (New York, New York). Just like during the supercycle, when people imagined commodity prices would go up forever, people now imagine a market that will never recover. But some analysts believe this downward cycle could be reversed by 2017.

Within this article: Details project spending Industrial Info is tracking for coal, copper, ferroalloys and iron.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News , or browse other breaking industrial news stories at www.industrialinfo.com .

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, five offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the www.industrialinfo.com " Contact Us " page.

Contact: Brian Ford (713) 980-9393

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insights from the New First Presidency on Global Challenges

Updated Category News Views 218

A Historic Conversation with the First Presidency The recent interview featuring the new First Presidency of The Church of Jesus Christ of Latter-day Saints marks an exciting milestone. Conducted by the talented Jane Clayson Johnson, this unique dialogue sheds light on pressing issues within the Church and broader society. It was their first public discussion, making it a...

Continue Reading
Major Bets on Donald Trump's Election Surge Past $52 Million

Updated Category News Views 119

Significant Bets on Trump's Electoral Success A trader on Polymarket, operating under the alias Fredi9999, alongside four other accounts, has made headlines recently by placing enormous bets on Donald Trump’s electoral prospects. This activity has generated considerable chatter among traders in the market. Tracking Trump's Betting Activity Harry Crane, a statistics...

Continue Reading
FMC Corporation Faces Lawsuit Over Securities Violations

Updated Category News Views 190

FMC Corporation Faces Lawsuit Over Securities Violations Recently, the Gross Law Firm has alerted shareholders of FMC Corporation (NYSE: FMC) regarding significant legal developments. This lawsuit brings attention to serious allegations concerning the company's conduct during a specific class period. Shareholder Engagement and Participation Shareholders who purchased FMC...

Continue Reading
Insider Buying at Optima Health Signals Confidence in Future Growth

Updated Category News Views 132

Insightful Insider Share Purchase at Optima Health Optima Health plc (AIM: OPT), a leading provider of corporate health and wellbeing solutions in the UK, recently announced an important transaction involving one of its key insiders. Joanne Newey, who takes on the role of Group Business Development & Propositions Director and is also a Person Discharging Managerial...

Continue Reading
Outlook Therapeutics Prepares for Upcoming Investor Interaction

Updated Category News Views 78

Outlook Therapeutics Connects with Investors at Upcoming Virtual Event ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK) has been making waves in the biopharmaceutical field with its groundbreaking ocular therapy. This marks an exciting era for the company following the recent approval of its eye treatment formulation of bevacizumab, which targets wet age-related...

Continue Reading